Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator
JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of
chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind,
active-controlled, randomised, phase 2b trial.

Yuen, Mf; Asselah, T; Jacobson, Im; Brunetto, Mr; Hla, Janssen; Takehara, T; Hou, Jl; Kakuda, Tn; Lambrecht, T; Beumont, M; Kalmeijer, R; Guinard-Azadian, C; Mayer, C; Jezorwski, J; Verbinnen, T; Lenz, O; Shukla, U; Biermer, M

doi:10.1016/S2468-1253(23)00148-6

Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial.

Yuen MF;Asselah T;Jacobson IM;Brunetto MR^{Writing – Original Draft Preparation};Janssen HLA;Takehara T;Hou JL;Kakuda TN;Lambrecht T;Beumont M;Kalmeijer R;Guinard-Azadian C;Mayer C;Jezorwski J;Verbinnen T;Lenz O;Shukla U;Biermer M

2023-01-01

Scheda breve

Scheda completa

Scheda completa (DC)

	Anno
	
				2023
			
	Codice DOI
	
				https://dx.doi.org/10.1016/S2468-1253(23)00148-6
			
	Tutti gli autori
	
						Yuen, Mf; Asselah, T; Jacobson, Im; Brunetto, Mr; Janssen, Hla; Takehara, T; Hou, Jl; Kakuda, Tn; Lambrecht, T; Beumont, M; Kalmeijer, R; Guinard-Azad...espandi

File in questo prodotto:

Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/1216397

Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni

2

ND

ND

CINECA IRIS Institutional Research Information System

Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial.

Yuen MF;Asselah T;Jacobson IM;Brunetto MR^{Writing – Original Draft Preparation};Janssen HLA;Takehara T;Hou JL;Kakuda TN;Lambrecht T;Beumont M;Kalmeijer R;Guinard-Azadian C;Mayer C;Jezorwski J;Verbinnen T;Lenz O;Shukla U;Biermer M

Writing – Original Draft Preparation

2023-01-01

Scheda breve

Scheda completa

Scheda completa (DC)

Attenzione

Citazioni

social impact

CINECA IRIS Institutional Research Information System

Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial.

Yuen MF;Asselah T;Jacobson IM;Brunetto MRWriting – Original Draft Preparation;Janssen HLA;Takehara T;Hou JL;Kakuda TN;Lambrecht T;Beumont M;Kalmeijer R;Guinard-Azadian C;Mayer C;Jezorwski J;Verbinnen T;Lenz O;Shukla U;Biermer M

Writing – Original Draft Preparation

2023-01-01

Scheda breve Scheda completa Scheda completa (DC)

Informazioni

Attenzione

Citazioni

social impact

Conferma cancellazione

Yuen MF;Asselah T;Jacobson IM;Brunetto MR^{Writing – Original Draft Preparation};Janssen HLA;Takehara T;Hou JL;Kakuda TN;Lambrecht T;Beumont M;Kalmeijer R;Guinard-Azadian C;Mayer C;Jezorwski J;Verbinnen T;Lenz O;Shukla U;Biermer M

Scheda breve

Scheda completa

Scheda completa (DC)